Brightsurf Science News & Current Events

June 14, 2014
Improving diet quality reduces risk for type 2 diabetes
Improving the overall quality of one's diet helps to prevent type 2 diabetes, independent of other lifestyle changes, according to a study presented at the American Diabetes Association's 74th Scientific Sessions.

New theory of diabetic complications' origin suggests need for new therapeutic approach
Use of antioxidants may be ineffective or even contribute to kidney disease and other complications of diabetes, rather than helping to treat such health problems.

Reversal of type 1 diabetes in mice may eventually help humans
Investigators at the University of Cincinnati have found a therapy that reverses new onset type 1 diabetes in mouse models and may advance efforts in combating the disease among humans.

Late-breaking observational data show patients with type 2 diabetes taking JANUVIA (sitagliptin) and metformin initiated insulin therapy at a slower rate compared to patients taking a sulfonylurea and metformin
Merck, known as MSD outside the United States and Canada, today announced results from a late-breaking observational study that assessed the differences in time to initiation of insulin use and the proportion of the population initiating insulin among patients with type 2 diabetes taking the combination of JANUVIA (sitagliptin) and metformin, and patients taking the combination of a sulfonylurea and metformin.

Research suggests benefits of canola oil for people with type 2 diabetes
Canola is Canada's oil and new research from St. Michael's Hospital suggests it should also be one of the oils of choice for people with type 2 diabetes.

Will diabetes patients benefit from the Affordable Care Act?
Specific parts of the new law, which will be phased in through 2020, will have a significant impact on patients with diabetes and prediabetes.

Fasting reduces cholesterol levels in prediabetic people over extended period of time
For prediabetics, many interventions focus on lifestyle changes and weight loss, but new research on periodic fasting has identified a biological process in the body that converts bad cholesterol in fat cells to energy, thus combating diabetes risk factors.

New post-hoc analysis shows patients with type 2 diabetes undergoing intensification of insulin therapy experienced less nighttime hypoglycemia while being treated with Januvia (Sitagliptin) compared to placebo
New post-hoc analysis shows patients with type 2 diabetes undergoing intensification of insulin therapy experienced less nighttime hypoglycemia while being treated with Januvia compared to placebo.
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.